141 related articles for article (PubMed ID: 34045664)
1. Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies.
Denisova E; Westphal D; Surowy HM; Meier F; Hutter B; Reifenberger J; Rütten A; Schulz A; Sergon M; Ziemer M; Brors B; Betz RC; Redler S
Cancer Gene Ther; 2022 Jun; 29(6):697-708. PubMed ID: 34045664
[TBL] [Abstract][Full Text] [Related]
2. Whole genome and whole transcriptome genomic profiling of a metastatic eccrine porocarcinoma.
Thibodeau ML; Bonakdar M; Zhao E; Mungall KL; Reisle C; Zhang W; Bye MH; Thiessen N; Bleile D; Mungall AJ; Ma YP; Jones MR; Renouf DJ; Lim HJ; Yip S; Ng T; Ho C; Laskin J; Marra MA; Schrader KA; Jones SJM
NPJ Precis Oncol; 2018; 2(1):8. PubMed ID: 29872726
[TBL] [Abstract][Full Text] [Related]
3. Eccrine porocarcinoma arising within an area of Bowen disease.
Lowney AC; Mc Aleer MA; O'Connor K; Fitzgibbon JF; Bourke JF
Clin Exp Dermatol; 2012 Mar; 37(2):136-8. PubMed ID: 21973218
[TBL] [Abstract][Full Text] [Related]
4. Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations.
Harms PW; Hovelson DH; Cani AK; Omata K; Haller MJ; Wang ML; Arps D; Patel RM; Fullen DR; Wang M; Siddiqui J; Andea A; Tomlins SA
Hum Pathol; 2016 May; 51():25-31. PubMed ID: 27067779
[TBL] [Abstract][Full Text] [Related]
5. Eccrine porocarcinoma of the external ear.
Watkins B; Urquhart AC; Holt JJ
Ear Nose Throat J; 2011 Aug; 90(8):E25-7. PubMed ID: 21853429
[TBL] [Abstract][Full Text] [Related]
6. High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma.
Westphal D; Garzarolli M; Sergon M; Horak P; Hutter B; Becker JC; Wiegel M; Maczey E; Blum S; Grosche-Schlee S; Rütten A; Ugurel S; Stenzinger A; Glimm H; Aust D; Baretton G; Beissert S; Fröhling S; Redler S; Surowy H; Meier F
Br J Dermatol; 2021 Dec; 185(6):1186-1199. PubMed ID: 34185311
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome sequencing and RNA sequencing analyses of acinic cell carcinomas of the breast.
Beca F; Lee SSK; Pareja F; Da Cruz Paula A; Selenica P; Ferrando L; Gularte-Mérida R; Wen HY; Zhang H; Guerini-Rocco E; Rakha EA; Weigelt B; Reis-Filho JS
Histopathology; 2019 Dec; 75(6):931-937. PubMed ID: 31361912
[TBL] [Abstract][Full Text] [Related]
8. [Multiple recurrent eccrine porocarcinoma with inguinal metastasis. A case report].
Acosta-Arencibia A; Abrante-Expósito B; Ramos-Gordillo M
Cir Cir; 2016; 84(1):73-6. PubMed ID: 26242821
[TBL] [Abstract][Full Text] [Related]
9. Metastatic eccrine porocarcinoma.
Rehal B; Merin MR; Barr K
Cutis; 2013 Aug; 92(2):67-70. PubMed ID: 24087778
[TBL] [Abstract][Full Text] [Related]
10. [A case report of eccrine porocarcinoma].
Fumo G; Piras V; Pilloni L; Ferreli C; Pau M
Clin Ter; 2015; 166(4):e273-5. PubMed ID: 26378762
[TBL] [Abstract][Full Text] [Related]
11. Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes.
Nepal C; Zhu B; O'Rourke CJ; Bhatt DK; Lee D; Song L; Wang D; Van Dyke AL; Choo-Wosoba H; Liu Z; Hildesheim A; Goldstein AM; Dean M; LaFuente-Barquero J; Lawrence S; Mutreja K; Olanich ME; Lorenzo Bermejo J; ; Ferreccio C; Roa JC; Rashid A; Hsing AW; Gao YT; Chanock SJ; Araya JC; Andersen JB; Koshiol J
J Hepatol; 2021 May; 74(5):1132-1144. PubMed ID: 33276026
[TBL] [Abstract][Full Text] [Related]
12. Eccrine porocarcinoma shares dermoscopic characteristics with eccrine poroma: A report of three cases and review of the published work.
Edamitsu T; Minagawa A; Koga H; Uhara H; Okuyama R
J Dermatol; 2016 Mar; 43(3):332-5. PubMed ID: 26333057
[TBL] [Abstract][Full Text] [Related]
13. Genetic changes in sweat gland carcinomas.
Takata M; Hashimoto K; Mehregan P; Lee MW; Yamamoto A; Mohri S; Ohara K; Takehara K
J Cutan Pathol; 2000 Jan; 27(1):30-5. PubMed ID: 10660129
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic characterization of malignant mixed tumor of the skin accompanied by eccrine porocarcinoma].
Zhou XF; Yan QG; Guo XJ; Gou XD; Han JQ; Ye JL; Zhang HY; Wang FM
Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):536-541. PubMed ID: 29996320
[No Abstract] [Full Text] [Related]
15. UV-induced local immunosuppression in the tumour microenvironment of eccrine porocarcinoma and poroma.
Puttonen M; Isola J; Ylinen O; Böhling T; Koljonen V; Sihto H
Sci Rep; 2022 Apr; 12(1):5529. PubMed ID: 35365704
[TBL] [Abstract][Full Text] [Related]
16. [Eccrine porocarcinoma of the scalp].
Ekmekcı S; Lebe B
Turk Patoloji Derg; 2013; 29(2):156-9. PubMed ID: 23661356
[TBL] [Abstract][Full Text] [Related]
17. [A Case of Breast Metastasis of Eccrine Porocarcinoma].
Mori T; Kitamura M; Tomida K; Kawai Y; Sakai S; Kaida S; Miyake T; Kitamura N; Akabori H; Yamaguchi T; Sonoda H; Shimizu T; Naka S; Tani M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2016-2018. PubMed ID: 28133207
[TBL] [Abstract][Full Text] [Related]
18. Recurrent Metastatic Eccrine Porocarcinoma: A Case Report and Review of the Literature.
Khaja M; Ashraf U; Mehershahi S; Ayyadurai P; Malik S
Am J Case Rep; 2019 Feb; 20():179-183. PubMed ID: 30739904
[TBL] [Abstract][Full Text] [Related]
19. [Eccrine Porocarcinoma: clinical-pathological study of 19 cases in the Instituto Nacional de Enfermedades Neoplásicas, Lima - Peru].
Casavilca S; Lama A; Guerrero M; Essary LR; Mantilla R; Cano L; Barrionuevo C
Rev Peru Med Exp Salud Publica; 2013 Jul; 30(3):437-40. PubMed ID: 24100819
[TBL] [Abstract][Full Text] [Related]
20. Malignant Eccrine Porocarcinoma in Finland During 2007 to 2017.
Meriläinen AS; Pukkala E; Böhling T; Koljonen V
Acta Derm Venereol; 2021 Jan; 101(1):adv00363. PubMed ID: 33313937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
